List of insiders holdings for Aquestive Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
2025-02-13 11:38:04 | 10,077,434 0 |
10,077,434 | Form 13G |
| 2 | BRATTON DOUGLAS K 10% Owner |
2025-02-13 11:38:04 | 10,077,434 0 |
10,077,434 | Form 13G |
| 3 | Barber Daniel President and CEO |
2025-03-11 17:47:06 | 1,423,173 0 |
1,423,173 | Form 4 |
| 4 | Schobel Alexander Mark Chief Innovation/Tech Officer |
2024-10-02 14:16:27 | 980,726 0 |
980,726 | Form 4/A |
| 5 | BRAENDER LORI J Chief Legal Officer |
2025-03-11 17:47:57 | 462,981 0 |
462,981 | Form 4 |
| 6 | Wargacki Stephen Chief Science Officer |
2025-03-11 17:49:10 | 408,552 0 |
408,552 | Form 4 |
| 7 | TOTH A ERNEST JR Chief Financial Officer |
2025-03-11 17:48:45 | 399,366 0 |
399,366 | Form 4 |
| 8 | Kendall Keith J CEO and President |
2022-03-14 11:24:23 | 375,000 0 |
375,000 | Form 4 |
| 9 | Kraus Carl N Chief Medical Officer |
2025-03-11 17:48:34 | 343,566 0 |
343,566 | Form 4 |
| 10 | Boyd Peter E. See Remark |
2025-03-11 17:47:19 | 343,323 0 |
343,323 | Form 4 |
| 11 | Jung Cassie Chief Operating Officer |
2025-03-11 17:48:57 | 335,526 2,000 |
337,526 | Form 4 |
| 12 | Cioffi Melina SVP, Regulatory Affairs |
2025-05-15 12:59:30 | 202,261 0 |
202,261 | Form 4 |
| 13 | Korczynski Sherry SVP Sales and Marketing |
2025-06-10 14:12:59 | 156,858 0 |
156,858 | Form 4 |
| 14 | Maxwell John T. SVP-Chief Financial Officer |
2020-08-19 08:55:53 | 150,614 0 |
150,614 | Form 4 |
| 15 | Cochran John Director |
2025-06-12 13:58:00 | 141,486 0 |
141,486 | Form 4 |
| 16 | BROWN GREGORY B Director |
2025-06-12 14:13:31 | 117,085 0 |
117,085 | Form 4 |
| 17 | Truitt Kenneth Chief Medical Officer |
2022-09-08 16:30:27 | 100,000 0 |
100,000 | Form 4 |
| 18 | Marshall Ken W. SVP, Chief Commercial Officer |
2023-08-09 16:30:32 | 75,000 0 |
75,000 | Form 4 |
| 19 | Wood Theresa SVP-HR and Org. Development |
2022-03-14 11:26:29 | 70,000 0 |
70,000 | Form 4 |
| 20 | COSTA SANTO J Director |
2024-06-21 13:50:10 | 55,327 0 |
55,327 | Form 4 |
| 21 | Scibetta James S Director |
2021-06-17 18:51:00 | 51,635 0 |
51,635 | Form 4 |
| 22 | Slatko Gary H SVP, Chief Medical Officer |
2020-03-18 16:48:39 | 50,000 0 |
50,000 | Form 4 |
| 23 | Taglietti Marco Director |
2025-06-12 13:57:23 | 42,000 0 |
42,000 | Form 4 |
| 24 | Jenkins Abigail L. Director |
2025-06-12 13:59:05 | 42,000 0 |
42,000 | Form 4 |
| 25 | MORRIS TIMOTHY E Director |
2025-06-12 13:59:22 | 42,000 0 |
42,000 | Form 4 |
| 26 | Krop Julie Director |
2025-06-12 13:59:37 | 42,000 0 |
42,000 | Form 4 |
| 27 | Lurker Nancy Director |
2021-06-17 18:51:09 | 20,000 0 |
20,000 | Form 4 |